82
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Serum adiponectin is a negative predictor of central arterial stiffness in kidney transplant patients

, , , , &
Pages 264-269 | Received 17 Jul 2015, Accepted 29 Jan 2016, Published online: 10 Mar 2016
 

Abstract

Background The role of adiponectin in arterial stiffness and its relationship to cardiovascular disease is not fully demonstrated and needs further elaboration. In this study, the association between adiponectin level and arterial stiffness is studied among kidney transplant patients. Material and methods Anthropometric data and biochemical data including fasting glucose, lipid profile, renal function and serum adiponectin were determined in 55 kidney transplant patients. Central arterial stiffness was measured and presented by carotid-femoral pulse wave velocity. Results Univariate linear analysis showed that body weight, waist circumference, brachial pulse pressure and body mass index were correlated positively with carotid-femoral pulse wave velocity in this patient group. However, logarithmically transformed adiponectin level (log-adiponectin) correlated negatively with carotid-femoral pulse wave velocity. In multivariate regression analysis of factors significantly associated with carotid-femoral pulse wave velocity, it showed that both log-adiponectin (β = −0.427; R2 = 0.205, p = 0.001) and body weight (β = 0.327; R2 =0.106, p = 0.007) were independently predictive of central arterial stiffness. Conclusion Our study suggests that fasting serum adiponectin is negatively associated with carotid-femoral pulse wave velocity, hence arterial stiffness, in kidney transplant patients.

Disclosure statement

The authors report no conflict of interest. The authors alone are responsible for the content and writing of the paper.

This work was supported by grants from Buddhist Tzu Chi General Hospital, Hualien, Taiwan (TCRD101-06).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.